These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32515104)

  • 1. Protocol endomyocardial biopsy beyond 6 months-It is time to move on.
    Oh KT; Mustehsan MH; Goldstein DJ; Saeed O; Jorde UP; Patel SR
    Am J Transplant; 2021 Feb; 21(2):825-829. PubMed ID: 32515104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection.
    Shah KB; Flattery MP; Smallfield MC; Merinar G; Tang DG; Sheldon EH; Thacker LR; Kasirajan V; Cooke RH; Hess ML
    Transplantation; 2015 Aug; 99(8):e75-80. PubMed ID: 25706277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).
    Wagner K; Oliver MC; Boyle GJ; Miller SA; Law YM; Pigula F; Webber SA
    Pediatr Transplant; 2000 Aug; 4(3):186-92. PubMed ID: 10933318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomyocardial Biopsy and Prevalence of Acute Cellular Rejection in Heart Transplantation.
    Sinphurmsukskul S; Ariyachaipanich A; Siwamogsatham S; Thammanatsakul K; Puwanant S; Benjacholamas V; Ongcharit P
    Transplant Proc; 2021; 53(1):318-323. PubMed ID: 33041079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of routine surveillance endomyocardial biopsy after 12 months post-heart transplantation.
    Lampert BC; Teuteberg JJ; Shullo MA; Holtz J; Smith KJ
    Circ Heart Fail; 2014 Sep; 7(5):807-13. PubMed ID: 25104042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation.
    Orrego CM; Cordero-Reyes AM; Estep JD; Loebe M; Torre-Amione G
    J Heart Lung Transplant; 2012 Aug; 31(8):845-9. PubMed ID: 22609184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era.
    Cusi V; Vaida F; Wettersten N; Rodgers N; Tada Y; Gerding B; Urey MA; Greenberg B; Adler ED; Kim PJ
    Transplantation; 2024 May; 108(5):1220-1227. PubMed ID: 38098137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection surveillance in pediatric heart transplant recipients: Critical reflection on the role of frequent and long-term routine surveillance endomyocardial biopsies and comprehensive review of non-invasive rejection screening tools.
    Power A; Baez Hernandez N; Dipchand AI
    Pediatr Transplant; 2022 May; 26(3):e14214. PubMed ID: 35178843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
    Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System.
    Pouliopoulos J; Anthony C; Imran M; Graham RM; McCrohon J; Holloway C; Kotlyar E; Muthiah K; Keogh AM; Hayward CS; Macdonald PS; Jabbour A
    Heart Lung Circ; 2024 Aug; 33(8):1173-1183. PubMed ID: 38604884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the complications of 5347 endomyocardial biopsies applied to patients after heart transplantation and with cardiomyopathies: a single-center study.
    Fiorelli AI; Benvenuti L; Aielo V; Coelho AQ; Palazzo JF; Rossener R; Barreto AC; Mady C; Bacal F; Bocchi E; Stolf NA
    Transplant Proc; 2012 Oct; 44(8):2473-8. PubMed ID: 23026623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of routine evaluations for rejection in patients greater than 2 years after heart transplantation.
    Golbus JR; Konerman MC; Aaronson KD
    ESC Heart Fail; 2020 Aug; 7(4):1809-1816. PubMed ID: 32489007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
    Winters GL; Loh E; Schoen FJ
    Circulation; 1995 Apr; 91(7):1975-80. PubMed ID: 7895355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
    Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
    Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection.
    Butler CR; Savu A; Bakal JA; Toma M; Thompson R; Chow K; Wang H; Kim DH; Mengel M; Haykowsky M; Pearson GJ; Kaul P; Paterson I
    J Heart Lung Transplant; 2015 May; 34(5):643-50. PubMed ID: 25934478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited utility of endomyocardial biopsy in the first year after heart transplantation.
    Hamour IM; Burke MM; Bell AD; Panicker MG; Banerjee R; Banner NR
    Transplantation; 2008 Apr; 85(7):969-74. PubMed ID: 18408576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term surveillance biopsy: Is it necessary after pediatric heart transplant?
    Peng DM; Ding VY; Hollander SA; Khalapyan T; Dykes JC; Rosenthal DN; Almond CS; Sakarovitch C; Desai M; McElhinney DB
    Pediatr Transplant; 2019 Feb; 23(1):e13330. PubMed ID: 30506612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis.
    Stehlik J; Starling RC; Movsesian MA; Fang JC; Brown RN; Hess ML; Lewis NP; Kirklin JK;
    J Heart Lung Transplant; 2006 Dec; 25(12):1402-9. PubMed ID: 17178332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.